Which has better valuation and earnings, CINGW or AIMDW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cingulate N/A N/A N/A N/A N/A Ainos $18.11K N/A N/A N/A N/A

Is CINGW or AIMDW more profitable?

Company Net Margins Return on Equity Return on Assets Cingulate N/A N/A N/A Ainos N/A N/A N/A

Which has stronger valuation and earnings, ALVOW or CINGW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $559.42M N/A N/A N/A N/A Cingulate N/A N/A N/A N/A N/A

Is ALVOW or CINGW more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A Cingulate N/A N/A N/A

Which has stronger valuation & earnings, ARAV or CINGW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aravive N/A N/A N/A -$0.90 N/A Cingulate N/A N/A N/A N/A N/A

Is ARAV or CINGW more profitable?

Company Net Margins Return on Equity Return on Assets Aravive N/A N/A N/A Cingulate N/A N/A N/A

Which has preferable valuation and earnings, CINGW or ACABW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cingulate N/A N/A N/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A

Is CINGW or ACABW more profitable?

Company Net Margins Return on Equity Return on Assets Cingulate N/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Which has preferable earnings and valuation, BFRIW or CINGW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biofrontera $43.20M N/A N/A N/A N/A Cingulate N/A N/A N/A N/A N/A

Is BFRIW or CINGW more profitable?

Company Net Margins Return on Equity Return on Assets Biofrontera N/A N/A N/A Cingulate N/A N/A N/A

Cingulate (CINGW) Competitors

$0.01 0.00 (0.00%)

As of 07/31/2026 04:00 PM Eastern

Compare

CINGW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Cingulate stock or one of its competitors? MarketBeat compares Cingulate with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cingulate include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW).

How does Cingulate compare to Ainos?

Cingulate (NASDAQ:CINGW) and Ainos (NASDAQ:AIMDW) are related companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

Company	Net Margins	Return on Equity	Return on Assets
Cingulate	N/A	N/A	N/A
Ainos	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cingulate	N/A	N/A	N/A	N/A	N/A
Ainos	$18.11K	N/A	N/A	N/A	N/A

In the previous week, Cingulate's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company	Overall Sentiment
Cingulate	Neutral
Ainos	Neutral

Summary

Ainos beats Cingulate on 1 of the 1 factors compared between the two stocks.

How does Cingulate compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Cingulate	N/A	N/A	N/A

In the previous week, Alvotech had 1 more articles in the media than Cingulate. MarketBeat recorded 1 mentions for Alvotech and 0 mentions for Cingulate. Alvotech's average media sentiment score of 0.67 beat Cingulate's score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company	Overall Sentiment
Alvotech	Positive
Cingulate	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$559.42M	N/A	N/A	N/A	N/A
Cingulate	N/A	N/A	N/A	N/A	N/A

Summary

Alvotech beats Cingulate on 3 of the 3 factors compared between the two stocks.

How does Cingulate compare to Aravive?

Aravive (NASDAQ:ARAV) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aravive	N/A	N/A	N/A	-$0.90	N/A
Cingulate	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Aravive	N/A	N/A	N/A
Cingulate	N/A	N/A	N/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Aravive's average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company	Overall Sentiment
Aravive	Neutral
Cingulate	Neutral

Summary

Aravive beats Cingulate on 2 of the 2 factors compared between the two stocks.

How does Cingulate compare to Atlantic Coastal Acquisition Corp. II?

Cingulate (NASDAQ:CINGW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are related companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cingulate	N/A	N/A	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A

In the previous week, Cingulate's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company	Overall Sentiment
Cingulate	Neutral
Atlantic Coastal Acquisition Corp. II	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Cingulate	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A

Summary

Cingulate and Atlantic Coastal Acquisition Corp. II tied by winning 0 of the 0 factors compared between the two stocks.

How does Cingulate compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

In the previous week, Biofrontera had 1 more articles in the media than Cingulate. MarketBeat recorded 1 mentions for Biofrontera and 0 mentions for Cingulate. Biofrontera's average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company	Overall Sentiment
Biofrontera	Neutral
Cingulate	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biofrontera	$43.20M	N/A	N/A	N/A	N/A
Cingulate	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Biofrontera	N/A	N/A	N/A
Cingulate	N/A	N/A	N/A

Summary

Biofrontera beats Cingulate on 2 of the 2 factors compared between the two stocks.

Get Cingulate News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CINGW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CINGW vs. The Competition

Export

Metric	Cingulate	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$11.49B	$6.81B	$12.55B
Dividend Yield	N/A	2.72%	2.59%	10.03%
P/E Ratio	N/A	796.38	282.12	24.83
Price / Sales	N/A	749.10	573.08	78.59
Price / Cash	N/A	14.82	28.60	46.71
Price / Book	N/A	10.32	11.02	6.15
Net Income	N/A	$2.81B	$3.49B	$347.61M
7 Day Performance	N/A	2.14%	0.47%	1.17%
1 Month Performance	N/A	-1.98%	-4.24%	-3.46%
1 Year Performance	N/A	157.82%	62.63%	19.43%

Cingulate Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CINGW Cingulate	N/A	$0.01 flat	N/A	-86.3%	$0.00	N/A	N/A	20	Gap Up
AIMDW Ainos	N/A	$0.09 +11.8%	N/A	N/A	$0.00	$18.11K	N/A	40	Gap Down
ALVOW Alvotech	N/A	$0.15 flat	N/A	-90.6%	$0.00	$559.42M	N/A	4	Gap Up
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	N/A	$0.00	N/A	N/A	15

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CINGW) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cingulate (CINGW) Competitors